221 related articles for article (PubMed ID: 29063849)
1. Prognostic Factors and Patterns of Locoregional Failure After Surgical Resection in Patients With Cholangiocarcinoma Without Adjuvant Radiation Therapy: Optimal Field Design for Adjuvant Radiation Therapy.
Ghiassi-Nejad Z; Tarchi P; Moshier E; Ru M; Tabrizian P; Schwartz M; Buckstein M
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):805-811. PubMed ID: 29063849
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma.
Murakami Y; Uemura K; Sudo T; Hashimoto Y; Nakashima A; Kondo N; Sakabe R; Ohge H; Sueda T
Ann Surg Oncol; 2011 Mar; 18(3):651-8. PubMed ID: 20945107
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy with gemcitabine and S-1 after surgical resection for advanced biliary carcinoma: outcomes and prognostic factors.
Murakami Y; Uemura K; Sudo T; Hashimoto Y; Nakashima A; Sakabe R; Kobayashi H; Kondo N; Nakagawa N; Sueda T
J Hepatobiliary Pancreat Sci; 2012 Jul; 19(4):306-13. PubMed ID: 22270151
[TBL] [Abstract][Full Text] [Related]
4. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies.
Jarnagin WR; Ruo L; Little SA; Klimstra D; D'Angelica M; DeMatteo RP; Wagman R; Blumgart LH; Fong Y
Cancer; 2003 Oct; 98(8):1689-700. PubMed ID: 14534886
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant gemcitabine therapy improves survival in a locally induced, R0-resectable model of metastatic intrahepatic cholangiocarcinoma.
Gürlevik E; Fleischmann-Mundt B; Armbrecht N; Longerich T; Woller N; Kloos A; Hoffmann D; Schambach A; Wirth TC; Manns MP; Zender L; Kubicka S; Kühnel F
Hepatology; 2013 Sep; 58(3):1031-41. PubMed ID: 23686746
[TBL] [Abstract][Full Text] [Related]
6. Locoregional recurrence after curative intent resection for intrahepatic cholangiocarcinoma: implications for adjuvant radiotherapy.
Song S; Kim K; Chie EK; Kim S; Park HJ; Yi NJ; Suh KS; Ha SW
Clin Transl Oncol; 2015 Oct; 17(10):825-9. PubMed ID: 26041722
[TBL] [Abstract][Full Text] [Related]
7. Gemcitabine-based adjuvant chemotherapy improves survival after aggressive surgery for hilar cholangiocarcinoma.
Murakami Y; Uemura K; Sudo T; Hayashidani Y; Hashimoto Y; Nakamura H; Nakashima A; Sueda T
J Gastrointest Surg; 2009 Aug; 13(8):1470-9. PubMed ID: 19421824
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors and patterns of recurrence after curative resection for patients with distal cholangiocarcinoma.
Zhou W; Qian L; Rong Y; Zhou Q; Shan J; Li P; Shi L; Liu H; Sun X
Radiother Oncol; 2020 Jun; 147():111-117. PubMed ID: 32268230
[TBL] [Abstract][Full Text] [Related]
9. Resection for hilar cholangiocarcinoma: analysis of prognostic factors and the impact of systemic inflammation on long-term outcome.
Dumitrascu T; Chirita D; Ionescu M; Popescu I
J Gastrointest Surg; 2013 May; 17(5):913-24. PubMed ID: 23319395
[TBL] [Abstract][Full Text] [Related]
10. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases.
de Jong MC; Marques H; Clary BM; Bauer TW; Marsh JW; Ribero D; Majno P; Hatzaras I; Walters DM; Barbas AS; Mega R; Schulick RD; Choti MA; Geller DA; Barroso E; Mentha G; Capussotti L; Pawlik TM
Cancer; 2012 Oct; 118(19):4737-47. PubMed ID: 22415526
[TBL] [Abstract][Full Text] [Related]
11. Predictors and patterns of recurrence after curative liver resection in intrahepatic cholangiocarcinoma, for application of postoperative radiotherapy: a retrospective study.
Gil E; Joh JW; Park HC; Yu JI; Jung SH; Kim JM
World J Surg Oncol; 2015 Jul; 13():227. PubMed ID: 26216347
[TBL] [Abstract][Full Text] [Related]
12. Failure patterns after curative resection for intrahepatic cholangiocarcinoma: possible implications for postoperative radiotherapy.
Yu W; Hu C; Shui Y; Wu K; Zhang L; Chen Y; Li C; Xu J; Wei Q
BMC Cancer; 2019 Nov; 19(1):1108. PubMed ID: 31727017
[TBL] [Abstract][Full Text] [Related]
13. [A case of curatively resected advanced intrahepatic cholangiocellular carcinoma through effective response to neoadjuvant chemotherapy].
Hashimoto K; Tono T; Nishida K; Nonaka R; Tsunashima R; Fujie Y; Fujita S; Fujita J; Yoshida T; Ohnishi T; Imaoka S; Monden T
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2083-5. PubMed ID: 25731430
[TBL] [Abstract][Full Text] [Related]
14. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.
Guglielmi A; Ruzzenente A; Campagnaro T; Pachera S; Valdegamberi A; Nicoli P; Cappellani A; Malfermoni G; Iacono C
World J Surg; 2009 Jun; 33(6):1247-54. PubMed ID: 19294467
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of adjuvant chemotherapy in T1N0M0 intrahepatic cholangiocarcinoma after radical resection.
Li XH; Zhao CY; Zhou EL; Lin XJ
BMC Cancer; 2022 Nov; 22(1):1159. PubMed ID: 36357848
[TBL] [Abstract][Full Text] [Related]
16. [A case of intrahepatic cholangiocarcinoma with peritoneal dissemination treated successfully with surgical resection and adjuvant chemotherapy].
Shiozaki S; Satoh D; Matsukawa H; Yamaguchi K; Takahashi K; Mimura N; Taguchi K; Araki H; Toshima T; Kato T; Miyake S; Miyoshi H; Yoshida K; Choda Y; Tokumoto N; Kanazawa T; Harano M; Ojima Y; Idani H; Okajima M; Ninomiya M
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2089-91. PubMed ID: 25731432
[TBL] [Abstract][Full Text] [Related]
17. The effect of adjuvant chemotherapy in patients with intrahepatic cholangiocarcinoma: a matched pair analysis.
Schweitzer N; Weber T; Kirstein MM; Fischer M; Kratzel AM; Reineke-Plaaß T; Lehner F; Manns MP; Vogel A
J Cancer Res Clin Oncol; 2017 Jul; 143(7):1347-1355. PubMed ID: 28314929
[TBL] [Abstract][Full Text] [Related]
18. Human equilibrative nucleoside transporter 1 expression predicts survival of advanced cholangiocarcinoma patients treated with gemcitabine-based adjuvant chemotherapy after surgical resection.
Kobayashi H; Murakami Y; Uemura K; Sudo T; Hashimoto Y; Kondo N; Sueda T
Ann Surg; 2012 Aug; 256(2):288-96. PubMed ID: 22580938
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trial.
Stein A; Arnold D; Bridgewater J; Goldstein D; Jensen LH; Klümpen HJ; Lohse AW; Nashan B; Primrose J; Schrum S; Shannon J; Vettorazzi E; Wege H
BMC Cancer; 2015 Jul; 15():564. PubMed ID: 26228433
[TBL] [Abstract][Full Text] [Related]
20. An assessment of risk factors for recurrence and survival for patients undergoing liver resection for intrahepatic cholangiocarcinoma.
Öztürk NB; Jamil LH
Eur J Gastroenterol Hepatol; 2024 Jun; 36(6):766-774. PubMed ID: 38683193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
